These findings suggest that the METTL16 and CAPN2 axis may play a particularly important role in pancreatic cancer progression, especially as we observed higher expression of CAPN2 in advanced-stage tumors and in tumor cell lines compared to normal pancreatic cells. This evidence concerns the gene METTL16 and familial pancreatic carcinoma.